latest news: Pharmaceuticals
Showing 10 of 74 Articles:
-
Qualitest: Idaho getting $87K from pharmaceutical agreement
Attorney General Lawrence Wasden announced Thursday that Idaho has joined 47 states and the federal government in a settlement agreement with Qualitest Pharmaceuticals. Qualitest is a manufacturer of generic pharmaceutical products, a wholly-owned subsidiary of Endo Pharmaceuticals. The settlement resolves allegations of unlawful labeling practices involving Qualitest-branded multivitamin tablets with fluoride, according to a news […]
United States, Idaho Pharmaceuticals -
FDA Warning Letter to Kirkman Laboratories over fluoride tablets
Public Health Service Food and Drug Administration Seattle District Pacific Region 22215 26th Avenue SE, Suite 210 Bothell, WA 98021 Telephone: 425-302-0340 FAX: 425-302-0402 January 13, 2016 OVERNIGHT DELIVERY SIGNATURE REQUIRED In reply refer to Warning Letter SEA 16-07 David K. Humphrey Chief Executive Officer and President Kirkman Laboratories, Inc. 10639 Professional Circle Reno, Nevada […]
United States, National USA Pharmaceuticals -
Is Fluoroquinolone Toxicity Quinolone Toxicity or Fluorine Toxicity?
As should be obvious from their name, FLUOROquinolones are fluorinated drugs. A little history for you: Nalidixic Acid is the backbone of all fluoroquinolones. It was discovered by George Lesher in 1962, and it started to be used as an antibiotic in 1967. Nalidixic acid, and the first-generation quinolones that were derived from it, were […]
International Pharmaceuticals -
Qualitest Pharmaceuticals settles with N.Y., other states in fluoride labeling case
New York recently joined up to 47 states and the federal government in an agreement with Qualitest Pharmaceuticals Inc. over allegations of unlawful labeling practices, Attorney General Eric T. Schneiderman announced. Owned by Endo Health Solutions, Qualitest manufactures generic pharmaceutical products. A whistleblower lawsuit was filed against the company, alleging Qualitest unlawfully labeled and marketed multivitamin […]
United States, New York United States Pharmaceuticals -
Qualitest: Vitamin maker agrees to $39 million settlement on fluoride content
A West Palm Beach attorney obtained a $39 million settlement with a pharmaceutical company whose chewable vitamins allegedly contained less than half the promised amount of fluoride. Endo Pharmaceuticals Inc. and seven subsidiaries agreed Thursday to pay the federal government and 26 state Medicaid programs, including Florida’s, to settle a whistleblower suit filed by dentist […]
United States, National USA Pharmaceuticals -
Qualitest: Endo Health to pay $39 million over fluoride labeling claims
A generic drug maker owned by Endo International Plc has reached a $39 million settlement with the U.S. government and 47 states stemming from the unlawful labeling of multivitamins that contained fluoride. New York Attorney General Eric Schneiderman announced the settlement on Wednesday. The case stemmed from a 2013 whistleblower lawsuit filed under the False […]
United States, New York Pharmaceuticals -
Manhattan U.S. Attorney announces $39 million civil fraud settlement against Qualitest Pharmaceuticals for selling half-strength fluoride supplements
Preet Bharara, the United States Attorney for the Southern District of New York, Scott J. Lampert, Special Agent in Charge of the New York Regional Office for the Office of Inspector General for the Department of Health and Human Services (“HHS-OIG”), and Diego Rodriguez, the Assistant Director-in-Charge of the New York Office of the Federal […]
United States, New York Pharmaceuticals -
Relaunching the power of fluorine
DuPont 2015 Chemistry Student Award winner Sébastien Alazet talks fluorine and how to reinvigorate a whole branch of chemistry… The fluorine atom is one of the most powerful atoms in the periodic table. Because of its specific properties – electronegativity, hydrophobicity and polarity – fluorine brings a crucial physico-chemical modification to molecules. Since isolation of […]
International Pharmaceuticals -
Graphene coating improves chemotherapy delivery
Using graphene to line drug-delivery catheters could improve the efficacy of chemotherapy, according to the findings of an international study. The research showed that the common drug 5-Fluorouracil (5-Fu) can interact with silver, a widely used catheter coating material. As a result, the 5-Fu may not deliver the desired therapeutic effect. Furthermore, the reaction may […]
Norway Pharmaceuticals -
Fluorourocil: Catheter studies raise acid alert
Chemotherapy treatments routinely deliver drugs via catheters, yet in 25% of these catheters there are complications that are generally not well understood. For the first time researchers have studied the behaviour of a common chemotherapy drug on silver, which is often used to coat catheters and other apparatus used in chemotherapy drug delivery. The studies […]
International Pharmaceuticals